Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Accelerate Diagnostics, IncAXDX · Entity 78156 | Director · Chief Executive Officer | April 04, 2025 | April 07, 2025 |
| BRUKER CORPBRKR · Entity 3609 | Director | February 15, 2026 | February 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Accelerate Diagnostics, Inc
Report date April 04, 2025 · Filed April 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 191,374 |
Ending reported balance
After 2025-04-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-04-04 · Exercise / conversion · Acquired 53,283 · Balance 216,717 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. Row 2 · 2025-04-04 · Sale · Disposed 25,343 · Balance 191,374 F2: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. |
| Employee Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-04-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-04-04 · Exercise / conversion · Disposed 53,283 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. F3: On April 4, 2022, the reporting person was granted a total of 88,806 RSUs, of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
F2: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
F3: On April 4, 2022, the reporting person was granted a total of 88,806 RSUs, of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025.
BRUKER CORP
Report date February 15, 2026 · Filed February 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,520 |
Reported balance
After 2026-02-15 transaction · row 1
1 source rowRow 1 · 2026-02-15 · Grant · Acquired 4,520 · Balance 4,520 F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2023 Filed May 16, 2023 17:38 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 7,940 | $0.69 | $5,478.60 |
DisclosureSEC source: 0001628280-23-018497 · wk-form4_1684273120.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492,638 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| May 15, 2023 Filed May 16, 2023 17:38 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 17,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-018497 · wk-form4_1684273120.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:51 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 17,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-011838 · wf-form4_168178267456187.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,732 Underlying: Common Stock · 17,216 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:51 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 7,444 | $0.65 | $4,838.60 |
DisclosureSEC source: 0001628280-23-011838 · wf-form4_168178267456187.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 483,361 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| April 13, 2023 Filed Apr 17, 2023 21:51 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 17,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-011838 · wf-form4_168178267456187.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 490,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 14:15 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 17,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008047 · wf-form4_167890411697773.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,217 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 14:15 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 7,451 | $0.49 | $3,650.99 |
DisclosureSEC source: 0001628280-23-008047 · wf-form4_167890411697773.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,589 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 14:15 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 17,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008047 · wf-form4_167890411697773.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 481,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. Read SEC document |
| March 08, 2023 Filed Mar 13, 2023 17:46 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 350,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-007740 · wf-form4_167874395738662.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 350,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 13, 2023 the reporting person was granted a total of 350,000 restricted stock units, which vested in full on March 8, 2023. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 13, 2023 the reporting person was granted a total of 350,000 restricted stock units, which vested in full on March 8, 2023. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 13, 2023 the reporting person was granted a total of 350,000 restricted stock units, which vested in full on March 8, 2023. Read SEC document |
| March 08, 2023 Filed Mar 13, 2023 17:46 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 155,635 | $0.47 | $73,148.45 |
DisclosureSEC source: 0001628280-23-007740 · wf-form4_167874395738662.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463,823 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 08, 2023 Filed Mar 13, 2023 17:46 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 350,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-007740 · wf-form4_167874395738662.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 619,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 13, 2023 the reporting person was granted a total of 350,000 restricted stock units, which vested in full on March 8, 2023. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 13, 2023 the reporting person was granted a total of 350,000 restricted stock units, which vested in full on March 8, 2023. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 18:30 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 17,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-003787 · wf-form4_167650379014802.xml · derivative · entry 4 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,216 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 18:30 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantEmployee Restricted Stock Units · Derivative | 350,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-003787 · wf-form4_167650379014802.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The reporting person received restricted stock units on February 13, 2023, which will vest on March 8, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 18:30 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 8,601 | $0.60 | $5,160.60 |
DisclosureSEC source: 0001628280-23-003787 · wf-form4_167650379014802.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,458 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 18:30 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 17,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-003787 · wf-form4_167650379014802.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. Read SEC document |
| February 01, 2023 Filed Feb 1, 2023 17:38 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-001937 · wf-form4_167529112436258.xml · derivative · entry 2 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 1, 2020, the reporting person was granted a total of 50,000 restricted stock units, which vests in five equal amounts each year. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 1, 2020, the reporting person was granted a total of 50,000 restricted stock units, which vests in five equal amounts each year. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 1, 2020, the reporting person was granted a total of 50,000 restricted stock units, which vests in five equal amounts each year. Read SEC document |
| February 01, 2023 Filed Feb 1, 2023 17:38 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-001937 · wf-form4_167529112436258.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 1, 2020, the reporting person was granted a total of 50,000 restricted stock units, which vests in five equal amounts each year. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 1, 2020, the reporting person was granted a total of 50,000 restricted stock units, which vests in five equal amounts each year. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:18 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 17,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-001132 · wf-form4_167399386630101.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,216 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:18 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 8,408 | $0.69 | $5,801.52 |
DisclosureSEC source: 0001628280-23-001132 · wf-form4_167399386630101.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,843 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:18 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 17,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-001132 · wf-form4_167399386630101.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,251 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 206,597 restricted stock units, which vests in equal amounts every month for 12 months. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 16:14 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 62,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-017975 · wf-form4_165610164099486.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,160 Underlying: Common Stock · 62,160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F1 · derivative.exercise_date: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F1 · derivative.expiration_date: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 16:14 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 28,198 | $0.91 | $25,660.18 |
DisclosureSEC source: 0001628280-22-017975 · wf-form4_165610164099486.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,035 F2 · shares: The reporting person received restricted stock units, of which vests in equal annual amounts on each anniversary of the grant date over three years, beginning on June 22, 2021 and ending on June 22, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 16:14 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 62,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-017975 · wf-form4_165610164099486.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F1 · price: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| April 28, 2022 Filed Apr 28, 2022 17:54 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 83,708 | $0.98 | $82,033.84 |
DisclosureSEC source: 0001628280-22-011207 · wf-form4_165118279704770.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,073 F2 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 28, 2022, the reporting person was granted a total of 168,396 restricted stock units, which vested April 26, 2022. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 17:54 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 168,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-011207 · wf-form4_165118279704770.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 168,396 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F1 · derivative.exercise_date: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F1 · derivative.expiration_date: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 17:54 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 168,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-011207 · wf-form4_165118279704770.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F1 · price: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 17:06 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantEmployee Restricted Stock Units · Derivative | 888,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-008605 · wf-form4_164927919947141.xml · derivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 888,060 Underlying: Common Stock · 888,060 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units on April 4, 2022, of which 40% vests on April 4, 2024 and the remaining 60% will vest on April 4, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 17:13 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantEmployee Restricted Stock Units · Derivative | 168,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-007912 · wf-form4_164867477654151.xml · derivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,396 Underlying: Common Stock · 168,396 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units on March 28, 2022, which vest on April 26, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| February 01, 2022 Filed Feb 7, 2022 17:21 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-001922 · wf-form4_164427244048223.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 01, 2020, the reporting person was granted a total of 50,000 restricted stock units, which vests in five equal annual amounts of 10,000 units starting on February 01, 2021. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 01, 2020, the reporting person was granted a total of 50,000 restricted stock units, which vests in five equal annual amounts of 10,000 units starting on February 01, 2021. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 01, 2020, the reporting person was granted a total of 50,000 restricted stock units, which vests in five equal annual amounts of 10,000 units starting on February 01, 2021. Read SEC document |
| February 01, 2022 Filed Feb 7, 2022 17:21 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 3,653 | $3.26 | $11,908.78 |
DisclosureSEC source: 0001628280-22-001922 · wf-form4_164427244048223.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,385 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| February 01, 2022 Filed Feb 7, 2022 17:21 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-001922 · wf-form4_164427244048223.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 01, 2020, the reporting person was granted a total of 50,000 restricted stock units, which vests in five equal annual amounts of 10,000 units starting on February 01, 2021. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 01, 2020, the reporting person was granted a total of 50,000 restricted stock units, which vests in five equal annual amounts of 10,000 units starting on February 01, 2021. Read SEC document |
| September 30, 2021 Filed Dec 10, 2021 15:57 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantCommon Stock | 4,340 | $7.68 | $33,331.20 |
DisclosureSEC source: 0001628280-21-024839 · wf-form4_163916982716598.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,038 F1 · shares: Represents shares purchased by the reporting person from Accelerate Diagnostics, Inc. in connection with the closing of the third and final tranche of an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. The third and final tranche of the offering closed on September 30, 2021. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 18:40 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 62,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-012872 · wf-form4_162457440970862.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,320 Underlying: Common Stock · 62,160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On June 22, 2020, the reporting person was granted a total of 186,480 restricted stock units, which vests in three equal annual amounts of 62,160 units starting on June 22, 2021. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On June 22, 2020, the reporting person was granted a total of 186,480 restricted stock units, which vests in three equal annual amounts of 62,160 units starting on June 22, 2021. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On June 22, 2020, the reporting person was granted a total of 186,480 restricted stock units, which vests in three equal annual amounts of 62,160 units starting on June 22, 2021. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 18:40 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 23,479 | $7.94 | $186,423.26 |
DisclosureSEC source: 0001628280-21-012872 · wf-form4_162457440970862.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,698 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 18:40 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 62,160 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-21-012872 · wf-form4_162457440970862.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On June 22, 2020, the reporting person was granted a total of 186,480 restricted stock units, which vests in three equal annual amounts of 62,160 units starting on June 22, 2021. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On June 22, 2020, the reporting person was granted a total of 186,480 restricted stock units, which vests in three equal annual amounts of 62,160 units starting on June 22, 2021. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:59 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantRestricted Stock Units · Derivative | 206,597 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-071493 · tm2117458d2_form4.xml · derivative · entry 1 Phillips Jack · CIK 0001784805 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,597 Underlying: Common Stock · 206,597 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest monthly in 12 equal amounts starting January 13, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 13, 2021 Filed May 14, 2021 16:21 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 25,064 | $6.76 | $169,432.64 |
DisclosureSEC source: 0001628280-21-010330 · wf-form4_162102369162063.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,017 F2 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| May 12, 2021 Filed May 14, 2021 16:21 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 79,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-010330 · wf-form4_162102369162063.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 79,893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 12, 2021, the reporting person was granted restricted stock units, which vested in full on May 12, 2021. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 12, 2021, the reporting person was granted restricted stock units, which vested in full on May 12, 2021. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 12, 2021, the reporting person was granted restricted stock units, which vested in full on May 12, 2021. Read SEC document |
| May 12, 2021 Filed May 14, 2021 16:21 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 79,893 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-21-010330 · wf-form4_162102369162063.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 12, 2021, the reporting person was granted restricted stock units, which vested in full on May 12, 2021. F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 12, 2021, the reporting person was granted restricted stock units, which vested in full on May 12, 2021. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 16:20 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantCommon Stock | 4,340 | $7.68 | $33,331.20 |
DisclosureSEC source: 0001628280-21-006839 · wf-form4_161834523863424.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,188 F1 · shares: Represents shares purchased by the reporting person from Accelerate Diagnostics, Inc. in connection with the closing of the second tranche of an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. The second tranche of the offering closed on April 9, 2021. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 16:58 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantEmployee Restricted Stock Units · Derivative | 79,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-004910 · wf-form4_161592828681021.xml · derivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,893 Underlying: Common Stock · 79,893 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units on March 12, 2021, which vest on May 12, 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 19:56 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantCommon Stock | 4,340 | $7.68 | $33,331.20 |
DisclosureSEC source: 0001104659-21-026982 · tm217603d2_4.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,848 F1 · shares: Represents shares purchased by the reporting person from Accelerate Diagnostics, Inc. in connection with the closing of the first tranche of an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. The first tranche of the offering closed on February 19, 2021. Read SEC document |
| February 02, 2021 Filed Feb 3, 2021 16:50 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 3,313 | $10.90 | $36,111.70 |
DisclosureSEC source: 0001628280-21-001393 · wf-form4_161238901803627.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,508 F1 · shares: Shares sold solely to pay taxes due upon the vesting of restricted stock units. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 16:50 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-001393 · wf-form4_161238901803627.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Accelerate Diagnostics, Inc. (the "Issuer"). F3 · derivative.exercise_date: On February 1, 2020, the reporting person was granted restricted stock units, which vest in equal annual amounts on each anniversary of the grant date over five years, beginning on February 1, 2021 and ending on February 1, 2025. Upon vesting, the reporting person will receive such number of shares of the Issuer's common stock equal to the number of restricted stock units that vested. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 16:50 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-001393 · wf-form4_161238901803627.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2020 Filed Feb 3, 2021 16:49 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | SaleCommon Stock | 1,542 | $7.37 | $11,364.54 |
DisclosureSEC source: 0001628280-21-001392 · wf-form4_161238893411612.xml · nonDerivative · entry 2 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,821 F2 · shares: Shares sold solely to pay taxes due upon the vesting of restricted stock units. Read SEC document |
| December 16, 2020 Filed Feb 3, 2021 16:49 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionEmployee Restricted Stock Units · Derivative | 5,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-001392 · wf-form4_161238893411612.xml · derivative · entry 3 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,363 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Accelerate Diagnostics, Inc. (the "Issuer"). F3 · derivative.exercise_date: On June 29, 2020, the reporting person was granted restricted stock units, which vested on December 16, 2020. Upon vesting, the reporting person received such number of shares of the Issuer's common stock equal to the number of restricted stock units that vested. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| December 16, 2020 Filed Feb 3, 2021 16:49 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | Exercise / conversionCommon Stock | 5,363 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-21-001392 · wf-form4_161238893411612.xml · nonDerivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Accelerate Diagnostics, Inc. (the "Issuer"). Read SEC document |
| June 29, 2020 Filed Jul 1, 2020 16:02 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantEmployee Restricted Stock Units · Derivative | 5,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-010100 · wf-form4_159363373353484.xml · derivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,363 Underlying: Common Stock · 5,363 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units on June 29, 2020, which vest on December 16, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 16:13 UTC | Accelerate Diagnostics, Inc AXDX · Entity 78156 | GrantEmployee Restricted Stock Units · Derivative | 186,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-009884 · wf-form4_159302958440067.xml · derivative · entry 1 Phillips Jack · CIK 0001784805 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,480 Underlying: Common Stock · 186,480 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units, of which vests in equal annual amounts on each anniversary of the grant date over three years, beginning on June 22, 2021 and ending on June 23, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.